← Back to Clinical Trials
Recruiting NCT06642285

NCT06642285 Effect of Implementing Evidence Based Practices on Prevention of Associated Nasal Pressure Injuries Among Preterm Neonates With Non-Invasive Respiratory Support

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06642285
Status Recruiting
Phase
Sponsor Kafrelsheikh University
Condition Mechanical Ventilation Complication
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2024-08-01
Primary Completion 2024-12-30

Eligibility & Interventions

Sex All sexes
Min Age 30 Weeks
Max Age 37 Weeks
Study Type INTERVENTIONAL
Interventions
Non Invasive Respiratory Support bundle

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2024-08-01 with a primary completion date of 2024-12-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to evaluate the effect of implementing evidence based practices on prevention of associated nasal pressure injuries among preterm neonates with non invasive respiratory support

Eligibility Criteria

Inclusion Criteria: * Preterm neonates receiving NIRS * whose gestational ages ranges between 30 and 37 weeks, and both genders Exclusion Criteria: * all preterm neonates not receiving NIRS, * have prior nasal trauma caused by tracheal intubation * or Infants exhibiting evidence of nasal damage during the NIRS procedure, * have upper respiratory abnormalities. * preterm neonates who have undergone any type of surgery and had life-threatening congenital abnormalities.

Contact & Investigator

Central Contact

Eman W abdelaal, Ass. Professor

✉ eman_wardany_2014@nur.kfs.edu.eg

📞 01065407334

Principal Investigator

Eman W Wardany, ass. professor

PRINCIPAL INVESTIGATOR

pediatric nursing department, faculty of nursing kafrelsheikh univeristy

Frequently Asked Questions

Who can join the NCT06642285 clinical trial?

This trial is open to participants of all sexes, aged 30 Weeks or older, up to 37 Weeks, studying Mechanical Ventilation Complication. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06642285 currently recruiting?

Yes, NCT06642285 is actively recruiting participants. Contact the research team at eman_wardany_2014@nur.kfs.edu.eg for enrollment information.

Where is the NCT06642285 trial being conducted?

This trial is being conducted at Kafr ash Shaykh, Egypt.

Who is sponsoring the NCT06642285 clinical trial?

NCT06642285 is sponsored by Kafrelsheikh University. The principal investigator is Eman W Wardany, ass. professor at pediatric nursing department, faculty of nursing kafrelsheikh univeristy. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology